In conclusion, our findings, as depicted in Fig. 9, indicate that TRIM26 serves as a viable regulator in the elimination of CEBPD during the pathological advancement of NASH. This evidence concerns the gene TRIM26 and metabolic dysfunction-associated steatohepatitis.